<DOC>
	<DOCNO>NCT00167479</DOCNO>
	<brief_summary>The specific aim study evaluate efficacy , tolerability , safety risperidone monotherapy treatment ambulatory bipolar disorder comorbid lifetime panic disorder generalize anxiety disorder current least moderately severe anxiety .</brief_summary>
	<brief_title>A Study Risperidone Monotherapy Bipolar Anxiety</brief_title>
	<detailed_description>This randomize , double-blind , placebo control , parallel-group , 8-week trial risperidone monotherapy outpatient subject lifetime bipolar I , II , NOS disorder , lifetime panic generalize anxiety disorder , current least moderately severe anxiety symptom . Approximately 90 subject enrol obtain 60 subject complete 8-week trial . Subjects randomize risperidone placebo 1:1 ratio . No concomitant psychotropic medication allow except prn lorazepam first two week management affective anxiety symptom , prn zolpidem zaleplon throughout study management insomnia . Throughout study , psychiatric scale use assess psychiatric symptom presence treatment-emergent adverse event monitor record .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>1 . Subjects must 18 year age old . 2 . Subjects must lifetime bipolar I , II , NOS disorder define DSMIV criterion . 3 . Subjects must lifetime panic disorder generalize anxiety disorder ( GAD ) define DSMIV criterion ( except clause “ occur exclusively mood disorder ” Criterion F GAD ) . 4 . Subjects ’ bipolar symptom must moderately severe , define CGIBP &lt; 4 . 5 . Subjects ’ anxiety symptom must least moderately severe , defined CGIS &gt; 4 . 6 . Subjects must receive mood stabilizing , antidepressant , antipsychotic , anxiolytic medication &gt; one week prior baseline . Patients receive fluoxetine depot antipsychotic medication &gt; four week prior baseline . 7 . Subjects legally authorize representative must sign Informed Consent Document nature trial fully explain . 8 . If female , subject must : postmenopausal , surgically incapable childbearing , practice medically acceptable effective method ( ) contraception ( e.g. , hormonal method , double barrier method , intrauterine device ) least one month prior study entry throughout study . 1 . Subjects lifetime bipolar disorder DSMIVTR criterion . 2 . Subjects lifetime panic disorder generalize anxiety disorder DSMIVTR criterion . 3 . Subjects receive treatment antimanic mood stabilize medication ( lithium , valproate , carbamazepine , antipsychotic ) , investigator ’ judgment , require ongoing treatment medication . 4 . Subjects whose bipolar symptom presently moderately severe ( CGIBP &gt; 5 ) . 5 . Subjects whose anxiety symptoms presently less moderately severe ( CGI &lt; 3 ) . 6 . Subjects clinically significant suicidal homicidal ideation . 7 . Subjects current psychotic symptom . 8 . Subjects current DSMIV Axis I diagnosis delirium , dementia , amnesia , cognitive disorder ; DSMIV diagnosis substance dependence disorder within past six month ; lifetime DSMIV psychotic disorder ( e.g. , schizophrenia schizoaffective disorder ) . 9 . Subjects serious general medical illness include hepatic , renal , respiratory , cardiovascular , endocrine , neurologic , hematologic disease determine clinical judgment clinical investigator . Subjects hypo hyperthyroidism unless stabilize thyroid replacement &gt; 3 month . 10 . Subjects clinically significant abnormality prestudy physical exam , vital sign , EKG , laboratory test . 11 . Subjects allergic demonstrate hypersensitivity risperidone . 12 . Women pregnant nursing . 13 . Subjects receive experimental drug use experimental device within 30 day . 14 . Subjects history neuroleptic malignant syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Bipolar Anxiety</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Panic Disorder</keyword>
	<keyword>Generalized Anxiety Disorder</keyword>
	<keyword>GAD</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Double-Blind</keyword>
	<keyword>Placebo Controlled</keyword>
</DOC>